关于 Ferric Carboxymaltose API

Product
  • CAS 编号

    9007-72-1

  • API 技术

    Iron Product

  • 剂型

    注射剂

  • Dr Reddy's 开发状态

    可用的

  • 可用的法规申报文件

    USDMF, 中国 DMF, 马来西亚 DMF, Saudi Arabia

Mechanism of Action

Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron.

Indication

Injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients:

  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron;
  • Who have non-dialysis dependent chronic kidney disease.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Ferric Carboxymaltose
Select Regulatory Requirements
Select Purpose

Related APIs

Ferric Carboxymaltose

Nephrology(肾脏科)

arrow

Iron Sucrose (蔗糖铁)

Nephrology(肾脏科)

arrow

Voclosporin(伏环孢素)

Nephrology(肾脏科)

arrow

Roxadustat Monohydrate (Form A & L-Proline)

Nephrology(肾脏科)

arrow

FAQs

What are the uses of Ferric Carboxymaltose API?
  • Treats iron deficiency anemia in patients intolerant to oral iron or with chronic kidney disease

What are the precautions to take while using Ferric Carboxymaltose API?
  • Monitor for allergic reactions
    Avoid in patients with severe renal impairment

How do you store Ferric Carboxymaltose API?
  • Store at 20°C to 25°C (68°F to 77°F), in a tightly closed container, protect from moisture

免责声明

本網站上的任何信息,包括對任何產品或服務的任何提及,均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是,在某些情況下,雷迪博士可自行決定並根據當地法律要求,在存在此類監管豁免的任何地方,提供此類產品的研究數量,以根據《印度專利法》第 107A 條(Bolar 豁免)進行監管提交。購買者應對其各自市場的產品或服務(包括專利情況)進行獨立評估,並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證,包括但不限於適銷性、適用於特定用途和非侵權的保證。

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patents Act (Bolar Exemption) and not for commercial sale.
羧基麦芽糖铁原料药生产商和供应商 | CAS 9007-72-1 - 瑞迪博士制药